Shanghai Shyndec Pharmaceutical (600420.SS) Earnings Analysis
Shanghai Shyndec Pharmaceutical (600420.SS) has no confirmed upcoming earnings date. Trailing P/E 16.51.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 600420.SS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 600420.SS. This page updates as the calendar is published.
600420.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-01-26 | 0.1 CNY | n/a | n/a | n/a |
| 2025-10-29 | 0.09626 CNY | n/a | n/a | n/a |
| 2025-07-17 | 0.2316 CNY | n/a | n/a | n/a |
| 2024-10-28 | 0.176 CNY | n/a | n/a | n/a |
600420.SS valuation and analyst view
| Trailing P/E | 16.51 |
|---|---|
| Trailing EPS | 0.53583 CNY |
| Price / book | 0.84 |
| Dividend yield | 3.45% |
| Market cap | 11.75B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Shanghai Shyndec Pharmaceutical (600420.SS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 600420.SS. This page updates as the calendar is published.
Did 600420.SS beat earnings last quarter?
Consensus estimate data was not available for 600420.SS's 2026-01-26 report.
What is 600420.SS's current P/E ratio and EPS?
600420.SS trades at a trailing P/E of 16.51 on trailing EPS of 0.5358297229120835 CNY.
What do analysts rate 600420.SS?
600420.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.